Genovese Burford & Brothers Wealth & Retirement Plan Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-27	Closed	-$3K	–	399
2018 Q2	$3K	Hold	27	–	–	﹤0.01%	396
2018 Q1	$3K	Hold	27	–	–	﹤0.01%	399
2017 Q4	$3K	Hold	27	–	–	0.01%	228
2017 Q3	$3K	Hold	27	–	–	﹤0.01%	368
2017 Q2	$3K	Hold	27	–	–	﹤0.01%	353
2017 Q1	$4K	Hold	27	–	–	﹤0.01%	375
2016 Q4	$3K	Hold	27	–	–	﹤0.01%	433
2016 Q3	$2K	Hold	27	–	–	﹤0.01%	400
2016 Q2	$3K	Hold	27	–	–	﹤0.01%	355
2016 Q1	$3K	Hold	27	–	–	﹤0.01%	336
2015 Q4	$4K	Buy	+27	New	+$3.94K	﹤0.01%	318

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Genovese Burford & Brothers Wealth & Retirement Plan Management's TARO Position: Q3 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2018, closing a stake of 27 shares — an estimated $3K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in TARO in Q4 2015 and held it in 11 quarters. The position peaked at $4K in Q1 2017. 114 funds tracked by Wall St. Rank hold TARO as of Q3 2018.

Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2018 after selling out during the quarter.
Genovese Burford & Brothers Wealth & Retirement Plan Management sold 27 Taro Pharmaceutical Industries Ltd. shares in Q3 2018, an estimated $3K.
Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 11 quarters.
Genovese Burford & Brothers Wealth & Retirement Plan Management's Taro Pharmaceutical Industries Ltd. position peaked at $4K in Q1 2017.
114 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q3 2018, filed 13 Nov 2018.